C07J 41/0011
Unsubstituted amino radicals
Official title: {Unsubstituted amino radicals}
C07J41/0011 (Unsubstituted amino radicals) appears on 97 US grants and 67 published applications in this corpus.
Search patents in C07J- Granted patents
- 97
- Published applications
- 67
- Assignees
- 71
- Inventors
- 233
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 1 | 0 |
| 2004 | 0 | 4 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 4 |
| 2014 | 0 | 5 |
| 2015 | 2 | 4 |
| 2016 | 3 | 4 |
| 2017 | 1 | 4 |
| 2018 | 5 | 4 |
| 2019 | 3 | 4 |
| 2020 | 2 | 2 |
| 2021 | 2 | 4 |
| 2022 | 3 | 3 |
| 2023 | 1 | 6 |
| 2024 | 2 | 1 |
| 2025 | 1 | 5 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Cyclin-dependent kinase degraders and methods of use10 Jun 2025US 12,325,725 B2Dana-Farber Cancer Institute, Inc.
- Neuroactive steroids, compositions, and uses thereof29 Oct 2024US 12,129,275 B2Sage Therapeutics, Inc.
- Small molecules active against gram-negative bacteria2 Jan 2024US 11,858,946 B2The Board of Trustees of the University of Illinois
- Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof3 Jan 2023US 11,542,298 B2Epirium Bio Inc.
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Cyclin-dependent kinase degraders and methods of use28 Aug 2025US 2025/0270252 A1Dana-Farber Cancer Institute, Inc.
- Neuroactive steroids, compositions, and uses thereof14 Aug 2025US 2025/0257092 A1Sage Therapeutics, Inc.
- Steroid compound, and preparation method therefor and application thereof15 May 2025US 2025/0154193 A1Cholesgen (Shanghai) Co., Ltd.
- Compositions for the delivery of payload molecules to airway epithelium13 Feb 2025US 2025/0049727 A1ModernaTX, Inc.
Most cited
By later US patents
- Oligonucleotide having enhanced binding affinity276US 5,486,603 AGilead Sciences, Inc. · 1996
- vitamin D.sub.3 derivatives having a substituent at 2-position96US 4,666,634 AChugai Seiyaku Kabushiki Kaisha · 1987
- Pharmaceutical compositions and methods of transporting compounds across biological membrane93US 5,455,335 AThe Trustees of Princeton University · 1995
- Specific binding assay method and reagent means83US 4,205,952 ATechnion Research & Development Foundation Limited · 1980
- Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments59US 5,512,558 AHoechst Aktiengesellschaft · 1996